Additionally, interventions with anticoagulant activity or anti-inflammatory activity did not appear to be harmful in patients with evidence of less coagulopathy (as assessed by coagulation tests) or less inflammation (as assessed by IL-6 levels). Here, IL6 is linked to blood coagulation disease.